Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Merrill

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Thrombosis and Haemostasis|June 12, 1999
Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding proteinJ T Merrill, H W Zhang, C Shen, et al.
Arthritis and Rheumatism|July 1, 1997
Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritisJ T Merrill, C Shen, D Schreibman, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Inhibition of methotrexate-induced rheumatoid nodulosis by colchicine: evidence from an in vitro model and regression in 7 of 14 patientsJ T Merrill, C Diakolios, S Goodman, et al.
Atmospheric Environment (Oxford, England : 1994)|May 28, 2020
Quantifying stratosphere-troposphere transport of ozone using balloon-borne ozonesondes, radar windprofilers and trajectory modelsD W Tarasick, T K Carey-Smith, W K Hocking, et al.
Annals of the Rheumatic Diseases|August 22, 2015
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled studyJ T Merrill, R F van Vollenhoven, J P Buyon, et al.
Lupus|August 1, 2007
Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosusJ A James, X R Kim-Howard, B F Bruner, et al.
Arthritis and Rheumatism|June 10, 2010
The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trialJ T Merrill, R Burgos-Vargas, R Westhovens, et al.
Annals of the Rheumatic Diseases|August 28, 2007
Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosusA H Sawalha, K M Kaufman, J A Kelly, et al.
Genes and Immunity|May 15, 2009
Evaluation of C1q genomic region in minority racial groups of lupusB Namjou, C Gray-McGuire, A L Sestak, et al.
Arthritis Care & Research|August 29, 2015
Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension StudyD J Wallace, K Hobbs, M E B Clowse, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Thrombosis and Haemostasis|June 12, 1999
Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding proteinJ T Merrill, H W Zhang, C Shen, et al.
Arthritis and Rheumatism|July 1, 1997
Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritisJ T Merrill, C Shen, D Schreibman, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Inhibition of methotrexate-induced rheumatoid nodulosis by colchicine: evidence from an in vitro model and regression in 7 of 14 patientsJ T Merrill, C Diakolios, S Goodman, et al.
Atmospheric Environment (Oxford, England : 1994)|May 28, 2020
Quantifying stratosphere-troposphere transport of ozone using balloon-borne ozonesondes, radar windprofilers and trajectory modelsD W Tarasick, T K Carey-Smith, W K Hocking, et al.
Annals of the Rheumatic Diseases|August 22, 2015
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled studyJ T Merrill, R F van Vollenhoven, J P Buyon, et al.
Lupus|August 1, 2007
Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosusJ A James, X R Kim-Howard, B F Bruner, et al.
Arthritis and Rheumatism|June 10, 2010
The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trialJ T Merrill, R Burgos-Vargas, R Westhovens, et al.
Annals of the Rheumatic Diseases|August 28, 2007
Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosusA H Sawalha, K M Kaufman, J A Kelly, et al.
Genes and Immunity|May 15, 2009
Evaluation of C1q genomic region in minority racial groups of lupusB Namjou, C Gray-McGuire, A L Sestak, et al.
Arthritis Care & Research|August 29, 2015
Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension StudyD J Wallace, K Hobbs, M E B Clowse, et al.
Pageof 7